X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 54 filers reported holding X4 PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,987 | -53.0% | 79,805 | -16.4% | 0.00% | – |
| Q2 2023 | $185,198 | -66.0% | 95,463 | -84.8% | 0.00% | – |
| Q1 2023 | $545,000 | +457883.2% | 626,047 | +423.5% | 0.00% | – |
| Q4 2022 | $119 | – | 119,598 | +58815.3% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 203 | -99.6% | 0.00% | – |
| Q2 2021 | $308,000 | -22.2% | 47,334 | +2.8% | 0.00% | – |
| Q1 2021 | $396,000 | +57.1% | 46,025 | +17.6% | 0.00% | – |
| Q4 2020 | $252,000 | +334.5% | 39,126 | +353.3% | 0.00% | – |
| Q3 2020 | $58,000 | -62.6% | 8,632 | -48.3% | 0.00% | – |
| Q2 2020 | $155,000 | +307.9% | 16,700 | +337.5% | 0.00% | – |
| Q1 2020 | $38,000 | -9.5% | 3,817 | -2.3% | 0.00% | – |
| Q4 2019 | $42,000 | -14.3% | 3,908 | +0.4% | 0.00% | – |
| Q3 2019 | $49,000 | +63.3% | 3,891 | +102.9% | 0.00% | – |
| Q2 2019 | $30,000 | +650.0% | 1,918 | +767.9% | 0.00% | – |
| Q1 2019 | $4,000 | – | 221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 12,202,510 | $10,616 | 1.33% |
| Tri Locum Partners LP | 3,878,484 | $3,374,281 | 1.03% |
| Lynwood Capital Management Inc. | 900,000 | $783,000 | 0.71% |
| NEA Management Company, LLC | 11,736,793 | $10,211,010 | 0.71% |
| Parkman Healthcare Partners LLC | 2,797,147 | $2,433,518 | 0.53% |
| SCOGGIN MANAGEMENT LP | 484,796 | $567,025 | 0.33% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $291,450 | 0.24% |
| Ghost Tree Capital, LLC | 850,000 | $740,000 | 0.22% |
| Perceptive Advisors | 4,545,454 | $3,954,545 | 0.12% |
| Orbimed Advisors | 5,817,726 | $5,061,422 | 0.10% |